Proteins containing the late embryogenesis abundant (LEA) motif comprise a conserved family, postulated to act as cell protectors. However, their function and mechanisms of action remain unclear. Here we show that PRELI, a mammalian LEAcontaining homolog of yeast Ups1p, can associate with dynamin-like GTPase Optic Atrophy-1 (OPA1) and contribute to the maintenance of mitochondrial morphology. Accordingly, PRELI can uphold mitochondrial membrane potential (DW m ) and enhance respiratory chain (RC) function, shown by its capacity to induce complex-I/NADH dehydrogenase and ATP synthase expression, increase oxygen consumption and reduce reactive oxygen species (ROS) production. PRELI can also inhibit cell death induced by STS, TNF-a or UV irradiation. Moreover, in vitro and in vivo dominant-negative overexpression of mutant PRELI/LEA À (lacking the LEA motif) and transient in vitro PRELI-specific knockdown can render lymphocytes vulnerable to apoptosis, cause mouse embryo lethality and revert the resistance of lymphoma cells to induced death. Collectively, these data support the long-presumed notion of LEA protein-dependent mechanisms of cytoprotection and suggest that PRELI interacts with OPA1 to maintain mitochondria structures intact, sustain balanced ion À /proton þ gradients, promote oxidative phosphorylation reactions, regulate pro-and antiapoptotic protein traffic and enable cell responses to induced death. These findings may help to understand how bioenergetics is mechanistically connected with cell survival cues. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation without specific permission.
PRELI opposes programmed cell death by intrinsic mechanisms that sustain mitochondrial structure, which in turn support the respiratory chain (RC), reduce reactive oxygen species (ROS) production and prevent the release of molecules that trigger caspase-dependent and independent apoptosis. We also show that functional interference by dominant-negative expression of mutant PRELI/LEA À proteins and transient siRNA-mediated PRELI knockdown can render chemoresistant lymphoma cell lines sensitive to apoptosis. These findings are also supported in vivo by the functional interference effects of PRELI/LEA À expression in ubiquitous and leukocyte-specific transgenic (Tg) mice, which led to embryo and neonatal lethality, thus suggesting that PRELI's function may be vital for embryonic and hematopoietic development.
Results
PRELI localizes in the mitochondrial IMS and associates with OPA1. In agreement with the cited structural predictions, [9] [10] [11] earlier studies have shown that MSF1-like/ LEA-containing proteins are expressed in the mitochondria. 5, 6, 8 As PRELI's yeast homolog Ups1p localizes within the mitochondrial intermembrane space (IMS), interacts with Mgm1, a yeast dynamin-associated GTPase equivalent of OPA1, and regulates mitochondrial shape, 8 we sought to determine whether comparable features apply to the mammalian protein. Congruent with the evolutionary parallel, transmission electron microscopy (TEM) shows that PRELI localizes in the IMS along mitochondrial cristae junctions, in which detection appears indistinguishable between the endogenous expression of the T47D breast carcinoma cell line 12 and enforced PRELI overexpression in the acute lymphocytic leukemia Blin-1 transfectant ( Figure 1 ). 13 PRELI expression was additionally examined by comparative immunoblots of cytosol, total mitochondria (TM), IMS and mitochondrial membrane (MM) protein fractions. We found that both PRELI and OPA1 are detectable in the IMS and prominently present in the MM fraction (Figure 2a ). The observed OPA1 doublet bands are consistent with large (L) and small (S) protein isoforms, 14 of which L2 and S4 are prominent. By fluorescence microscopy, we also observed that PRELI and OPA1 colocalize in the mitochondria (Figure 2b ), insinuating their potential biochemical interactions. Immunoprecipitation (IP)/immunoblot experiments reveal that PRELI can co-immunoprecipitate with prominent OPA1 isoforms and thus provide support to their predicted biochemical interactions (Figure 2c ). These interactions could be relevant to maintain mitochondrial cristae junctions tight and prevent cytochrome c (CytC) release. Consistent with this reasoning, treatment of vector transfectants with the kinase inhibitor staurosporine (STS) caused alterations of mitochondrial morphology (Figure 2d Figure S1 ). Of note, IP results show that both full-length PRELI and mutant PRELI/LEA À (which lacks the LEA motif) can associate with OPA1 isoforms. This implies that whereas the LEA sequence is dispensable for protein binding, it may be required for PRELI-dependent functions.
PRELI but not PRELI/LEA
À can uphold mitochondrial DW m . Under homeostatic conditions, the DC m -sensitive JC-1 probe aggregates in the mitochondria and emits red fluorescence (Figure 3a) . However, exposure to STS causes mitochondria to dissipate the DC m , preventing JC-1 aggregation and resulting in green fluorescence emission. The STS-triggered red-to-green fluorescence shift was detectable in the wild type (WT) and in vector transfectants, yet was absent in PRELI Blin-1 transfectants (Figure 3a) . Similar effects were observed with TNF-a and UV radiation (Figure 3a) . In striking contrast to full-length PRELI, mutant PRELI/LEA À expression was completely incapable to uphold mitochondrial DC m , induced by STS, TNF-a and UV radiation ( Figure 3a) . As it can be also corroborated in Figure 3a , mutant PRELI/LEA À could not prevent the mitochondrial damage caused by the apoptosisinducing stimuli. These data collectively suggest that although PRELI/LEA À retains protein binding capacity, its altered structure resulting from loss of the LEA motif could hamper the required conformation for physiological cooperation with OPA1 to preserve mitochondrial cristae junctions intact. Disruption of energy production by RC inhibitors and uncouplers alters mitochondrial DC m and causes apoptosis. 15 For instance, rotenone inhibits RC complex-I and depletes ATP pools, 16, 17 whereas carbonyl cyanide m-chlorophenylhy- À or untagged PRELI Blin-1 transfectants. IP was respectively performed with agarose-conjugated anti-V5 antibody or rabbit polyclonal anti-PRELI IgG, whose immunocomplexes were subsequently precipitated by agarose-conjugated protein-A. Immunoblots were revealed with monoclonal anti-OPA-1 IgG. Control input protein lysate (IN) was used to the minimum to simply control for positive immunoreaction, whereas a total precipitate from 1.0 mg of protein lysate was loaded onto the respective IP lanes. The distinct OPA1 protein L1, L2, S3, S4 and S5 isoforms present in both PRELI and PRELI/LEA À immunocomplexes are indicated. The IP specificity was routinely controlled by the exclusive detection of mitochondrial COX-IV in the input but not in the IP lanes. (d) Comparative immunofluorescent detection of mitochondrial Hsp60 (green fluorescence) between vector and PRELI Blin-1 transfectants to monitor the morphology of mitochondria in the absence (left frames) or presence (right frames) of STS. (e) Confocal microscopy to compare CytC's (in red) sub-cellular distribution between vector and PRELI Blin-1 transfectants incubated in the absence (upper panels) or presence (lower panels) of STS. The detection of Hsp60 (in green) was used as a mitochondrial reference and the TO-PRO fluorochrome (shown herein in blue) served as nuclear counterstain drazone (CCCP) pumps protons through mitochondrial inner membrane, thus uncoupling RC and hampering ATP production. 18, 19 Hence, to investigate whether PRELI can uphold mitochondrial DC m challenged by the complex-I inhibitor and the protonophore, vector, PRELI and PRELI/LEA À Blin-1 transfectants were treated with rotenone or CCCP. Flow cytometric experiments show that although PRELI-expressing cells can effectively counter rotenone-and CCCPinduced mitochondrial depolarization, the vector and PRELI/ LEA À transfectants could not prevent the effects of the complex-I inhibitor and protonophore (Figure 3b ).
PRELI effects on mitochondrial respiration. RC drives protons from the mitochondrial matrix to the IMS and creates a DC m . 19 As rotenone is applied to assess RC contribution to mitochondrial DC m and apoptosis, 16, 17 we sought to investigate whether PRELI's capacity to uphold mitochondrial DC m against complex-I inhibition is mechanistically connected to oxidative phosphorylation. To test this, we measured oxygen consumption in vector, PRELI and PRELI/LEA À transfectants in the absence or presence of rotenone. After rotenone treatment, cells were permeabilized for substrate (succinate) uptake to assess RC complex II-to- Figure S2) . Logical to the notion that CCCP's effects are independent of mitochondrial DC m and apoptosis, [16] [17] [18] [19] PRELI's influence on the protonophore RC uncoupling appeared unremarkable (data not shown).
Mitochondria generate energy through RC oxidative phosphorylation, which transfers electrons from NADH to O 2 molecules and leads to ATP synthesis. 20 RC reactions depend on complex-I redox functions to create asymmetric electron/proton gradients across the inner mitochondrial membrane (IMM). 20 These gradients produce a mitochondrial DC m , critical to restrain O 2 or H 2 O 2 (ROS) surges, and prevent the release of apoptogenic molecules. 21 To investigate whether PRELI plays any role in the mechanisms that connect bioenergetics with cell survival/death signals, genome-wide expression analyses were performed between vector and PRELI transfectants. We found that PRELI selectively induced RC complex-I NADH dehydrogenase expression, which, in contrast with vector transfectants, was virtually unaffected by STS treatment (Figure 4b and c). STS was used in these experiments to underscore the putative connection between the RC and apoptosis-mediated signaling.
Strikingly, whereas compensatory reductions of complex-II, III and IV expression were evident in PRELI transfectants, ATP synthase (complex-V) expression proceeded with higher Figure 4b) . Notably, the reduced complex-IV expression observed in PRELI transfectants agrees with the notion that at high ATP/ADP ratios, COX-IV is allosterically inhibited 22 ( Figure 4b ). Moreover, the finding that PRELI enhances complex-I expression is relevant because as a central entry site of electrons, COX-I is vulnerable to RC inhibitors 16, 17 and a major source of premature O 2 leakage and ROS production. 23 Remarkably, induction of PRELI/ LEA À expression resulted in substantive STS-mediated decrease of complex-I, IV and ATP synthase (complex-V) in conjunction with massive mitochondrial depolarization ( Figure  4b and c), further supporting the physiological requirement of PRELI's LEA motif.
Effect of PRELI on caspase activation and apoptosis. CytC is a molecular component of RC electron transfer reactions, 24, 25 which resides in the mitochondria but is released to the cytosol upon induction of apoptosis ( Figure 2e and Supplementary Figure S1a ). Released CytC binds to the apoptotic protease-activating factor-1 (Apaf-1) and triggers Apaf-1 oligomerization 26 to recruit procaspase-9 molecules, which undergo autocatalytic cleavage activation. 26 Caspase-9 then activates the downstream caspases and promotes DNA fragmentation. 27 To determine the effect of PRELI's expression on caspase activity, vector and PRELI transfectants were subjected to STS treatment. Figure 5a shows that vector but not PRELI transfectants undergo STS-induced, cleavage-dependent activation of caspase-9, 8 and 3. As caspase-3 activation mediates endonuclease-dependent DNA cleavage, 27 we tested the effect of PRELI on this function. We found that whereas 56% of vector transfectants undergo sub-G 1 DNA Signs of apoptosis include disruption of the plasma membrane, characterized by exposure of phosphatidylserine (PS) residues. 28 Accordingly, increased numbers of Annexin-V þ WT and vector transfectants were detected after STS treatment, whereas the number of Annexin-V þ cells in PRELI transfectants was significantly reduced (Figure 5c ). The functional requirement of the LEA motif was further noted by the evidence that PRELI/LEA À expression was completely unable to confer cytoprotection (Figure 5c ). In added support of PRELI's contribution to cell survival, genome-wide expression analyses revealed a selective increase in survivin expression by PRELI-expressing cells. Figure 5d shows that, whereas survivin level is low and undergoes further decrease in the STS-treated vector transfectants, its levels were routinely enhanced in PRELI transfectants and virtually unaffected by STS. The level of cIAP, which like survivin is a member of the inhibitors of apoptosis (IAP) family, was decreased in the STS-treated vector transfectants, but was only minimally stabilized by PRELI expression (Figure 5d ). Moreover, levels of XIAP, a third member of the IAPs, were consistently low and virtually unaffected under all the conditions examined (also depicted in Figure 5d ). Together these results underscore the selective impact of PRELI on survivin's expression.
Effect
of PRELI on caspase-independent apoptosis. Death signals can trigger both caspasedependent and independent apoptosis, and apoptosisinducing factor (AIF) is the best-characterized mediator of the latter. 29 To investigate whether PRELI plays any role in caspase-independent mechanisms, WT and vector, PRELI and PRELI/LEA À transfectants were subjected to apoptosis treatments and analyzed for AIF's sub-cellular distribution. Figure 6a shows that treatment of WT and vector transfectants with STS, TNF-a and UV radiation caused alterations in mitochondrial morphology and induced AIF nuclear translocation. Conversely, PRELI expression appeared to be sufficient to preserve mitochondrial structures and prevent AIF nuclear translocation (Figure 6a ). We also found that though both PRELI and PRELI/LEA À could bind to AIF (Figure 6b ), only the fulllength protein could counter mitochondrial damage and prevent AIF nuclear translocation caused by STS, TNF-a and UV radiation (Figure 6a and replicate insert in Figure 6b ). These results are consistent with the capacity of PRELI and PRELI/LEA À to bind to OPA1 and therefore provide additional support to the hypothesis that sustains that the LEA motif is dispensable for protein binding, but essential for PRELI-mediated mitochondrial structure and function stability and for ultimate cytoprotection.
Endogenous PRELI expression may confer resistance to apoptosis. The observation that enforced PRELI overexpression prevents STS, TNF-a and UV radiationinduced apoptosis, prompted the hypothesis of PRELIdependent mechanisms of cell resistance against induced death. After a comprehensive screening, we found that PRELI's expression is variable among leukemia and lymphoma cell lines (Supplementary Figure S3a) . For instance, the Burkitt's B-cell lymphoma line Raji had high endogenous PRELI levels and was relatively resistant to STS-induced apoptosis. Conversely, its counterpart Daudi expressed low PRELI levels and was highly sensitive to STS (Supplementary Figure S3b) . Moreover, the B-cell lymphoma line JY 30 exhibited high endogenous levels and was virtually insensitive to STS-, TNF-a-and Fas-induced apoptosis (Supplementary Figure S3c) . Thus, in view of the seemingly futile PRELI/LEA À function, we reasoned that enforced overexpression of the mutant protein could potentially interfere with endogenous PRELI expression. To test this hypothesis, tetracycline-inducible (Tet-ON)-PRELI/ LEA À JY cell lines (JY/Tet-ON) were generated and tested (Supplementary Figure S3d) . We observed that without induction there was neither significant PRELI/LEA PRELI knockdown renders cells susceptible to apoptosis. To further support PRELI's involvement in JY lymphoma resistance to apoptosis, small interference RNAs (siRNAs) were designed and tested for their capacity to knockdown endogenous PRELI expression and counter its cytoprotective function (Supplementary Figure S4) . After loading JY cells with non-targeting or PRELI-specific siRNAs by transitional pinocytosis, 31 cells were tested for apoptosisinduced DNA fragmentation. Flow cytometry shows that only 3.8% of JY cells loaded with non-targeting siRNA exhibited sub-G DNA fragments after STS treatment (Figure 7b ). In contrast, PRELI siRNA increased the number of JY cells undergoing DNA fragmentation to 13.8% (Figure 7b ). These data support the involvement of PRELI in the mechanisms that confer JY lymphoma resistance to apoptosis.
LEA requirement for in vivo PRELI's function. PRELI is ubiquitously expressed throughout embryo development (data not shown) and possesses in vitro LEA-dependent capacity to oppose apoptosis. Thus, to investigate in vivo the physiological significance of PRELI's expression, we generated Tg mice in which PRELI/LEA À expression is under the control of the SR-a promoter 32 and histidine (His)-tagged to ensure ubiquitous detection. After failing to obtain viable Tg mice (three pro-nuclear injections and 11 Tg embryos), we found that, contrary to WT littermates, PRELI/LEA À Tg mice did not survive past 10 days post coitus (dpc). We noted that while WT embryos developed normally, PRELI/LEA À Tg embryos were significantly smaller and underdeveloped PRELI has been detected in the thymus, spleen and peripheral blood leukocytes (PBLs) and appears to be prominently expressed by B and T lymphocytes in adult mice (data not shown). We therefore examined in vivo the consequence of PRELI/LEA À overexpression on lymphocyte development. Mice (eight Tg pups from two pronuclear injections) carrying the PRELI/LEA À transgene under the control of the hematopoiesis-specific vav promoter 33 died perinatally. The deaths ranged from a majority (high copy number) succumbing immediately after birth (data not shown) to a few (low-copy number) Tg mice that survived 4-5 weeks. Compared with WT littermates, vav-driven PRELI/LEA À Tg mice exhibited profound lymphopenia (data not shown), had smaller spleens and showed decreased numbers of CD45R/ B220 þ B lymphocytes (Figure 8d ). In agreement with the notion of vav preferential expression within the T-lymphocyte compartment 33 and consistent with the virtual absence of CD3 þ T-cells in the spleen (Figure 8d ), only thymus remnants were found in vav-driven PRELI/LEA À Tg mice, without detectable CD3 þ thymocytes (Figure 8d ). Together, these data highlight the vital PRELI physiology and the essential requirement of its LEA motif.
Discussion
Eukaryotes respond to stress stimuli by adaptive mechanisms that activate stress-response gene expression.
1 Among those, the LEA genes encode an evolutionarily conserved family of proteins long presumed to protect cells from stress and death. 2, 3 However, the physiology of LEA-containing proteins and the mechanisms connecting to cytoprotection remained unsolved.
The present study postulates that PRELI, a mammalian LEA-containing protein, may play a role in conserved mechanisms that integrate mitochondrial energy functions with cell responses to death-inducing stimuli. In keeping with this premise, phylogenetic evidence of LEA-like mediated cytoprotection continues to mount. For instance, expression of the avian PRELI ortholog pX19 can be triggered in response to stress-inducing bromodeoxyuridine and appears critical for hematopoietic development; 4 Drosophila prel þ T-cells (Brown reaction). The bottom panels depict thymus tissue sections analyzed for size, morphology and presence of CD3 þ thymocytes. Isotype-matched IgGs are shown in the spleen and thymus panels as negative controls (PRELI-like), slmo (slowmo) and retm (real-time) constitute a novel family of mitochondrial proteins that share PRELI/ MSF1-like domains and are activated during embryo development; 5 Ups1p, a yeast PRELI ortholog, is expressed within mitochondrial IMS and required for sorting and topogenesis of Mgm1p (yeast OPA1), 8, 34, 35 which is known to regulate mitochondrial shape. 8 Like Mgm1p, OPA1 is a dynaminassociated protein that protects cells from apoptosis by maintaining mitochondrial cristae integrity and keeping their junctions tight during induction of apoptosis, thereby preventing the release of CytC. 34, 35 Coherent with the evolutionary parallels, the present study shows that PRELI is expressed within the IMS in intimate proximity to mitochondrial cristae junctions. We also show that PRELI can associate with OPA1 and support mitochondria morphology. We therefore contend that PRELI's cooperation with OPA1 to maintain mitochondria cristae junctions tight is fundamental to maintain electron/proton gradients, 36 transduce signals relevant to RC oxidative phosphorylation/ATP synthesis and ROS production, 36 and regulate the sorting of pro-and antiapoptotic molecules. Notably, we show that PRELI expression can uphold mitochondrial DC m , enhance RC complex-I NADH dehydrogenase and ATP synthase expression, increase O 2 consumption, reduce ROS production and sustain robust survivin protein levels, while preventing CytC and AIF exit from the mitochondria.
These findings suggest that analogous to other proteins, PRELI could exert both nuclear and mitochondrial functions. Congruent with this reasoning, bioinformatics data reveal that PRELI possesses nuclear localization signals (NLS) and DNA/RNA-binding domains. 37 Alternatively, PRELI/OPA1 interactions at cristae junctions could transduce intra-mitochondrial signals, leading to activation of NADH dehydrogenase transcription from mtDNA loci. The evidence that oxidative phosphorylation subunits are also encoded by mtDNA suggests that alternative mechanisms are at least plausible for RC gene regulation. 38 Then, to reconcile the enhanced survivin expression with PRELI's functions in the mitochondria, we must note that previous studies have shown that Hsp60, a mitochondrial chaperon, can bind to survivin and increase its stability. 39 Accordingly, we speculate that in its MSF1-like protein-sorting capacity, PRELI could cooperate with Hsp60 to enhance survivin stability and coordinate its mitochondrial release. Coherently, PRELI and Hsp60 colocate in the mitochondria (not shown), which makes the potential cooperation persuasive.
In assessing the nature of potential PRELI interactions with other proteins, we sought to investigate whether the LEA sequence was required for protein binding and function. Since the experiments revealed that the LEA motif is dispensable for protein binding, the results appeared to be conflicting with PRELI's LEA-dependent cytoprotection. However, PRELI possesses PH, PTB, ENTH-like and FERM protein-binding capacity within the MSF1-like region, 9,10 which could help reconcile LEA-independent PRELI protein binding with LEAdependent functions. Furthermore, PRELI's low-complexity a-helix structure at the LEA domain appears to be attuned with homodimer protein conformations. Thus, congruent with the functional requirement of the LEA sequence, we postulate that PRELI could form a-helix-dependent homodimers to achieve functions relevant to mitochondrial activity and cytoprotection (Supplementary Figure S5a) . Preliminary protein purification experiments suggest that PRELI dimmer configuration may be plausible (not shown).
Of note, the present study finds that in most leukemia and lymphoma cell lines examined, the levels of PRELI expression are inversely proportional to the cell's response to apoptosisinducing stimuli, namely, low PRELI expression equals sensitivity and high levels square with resistance. In keeping with these observations, we found that dominant interference with endogenous PRELI function by inducible PRELI/LEA À overexpression or transient PRELI-specific knockdown can revert the resistance of lymphoid tumors, like the JY lymphoma cells, to apoptosis.
Lastly, a recent study reports that PRELI induces apoptosis in human primary T-helper (Th) cells. 40 Whereas it may be tenable that T and B lymphocytes respond to death-inducing stimuli through independent mechanisms, the findings and conclusions of the report appear at odds with the evolutionarily conserved cytoprotection associated to all LEA-containing proteins studied thus far.
In conclusion, this work provides experimental support to the long-standing prediction that LEA-containing proteins function as cell protectors. We also propose that, in view of the striking evolutionary conservation, PRELI and its homologs in other eukaryotes are bona fide antagonists of programmed cell death. While we remain cautious, we submit that our collective data might shed new information on how mitochondrial bioenergetics may be connected with mechanisms of cytoprotection and resistance to induced death. Mitochondrial DW m and ROS production. WT and Blin-1 transfectants were incubated for 4 h at 371C, with or without 1 mM STS or 20 ng/ml TNF-a. For UV radiation experiments, cells were suspended in phosphate-buffered saline (PBS) and exposed for 20 min to 1.5 kJ/m 2 of UVB radiation (290-320 nm) and incubated at 371C in fresh culture media for 4 h. Cells were next stained with a JC-1 probe (Clontech, Mountain View, CA, USA) for 20 min at 371C, washed, cytocentrifuged onto slides (Thermo Shandon, Oak Park, MI, USA), fixed and analyzed by fluorescence microscopy. In alternate experiments, transfectants were incubated for 4 h at 371C, in the absence or presence of either 1 mM CCCP or 2 mM rotenone. After JC-1 staining, cells were analyzed by flow cytometry. The red-to-green fluorescence shift was monitored in FL1 and FL2 channels. ROS production by PRELI/LEA Respiration rate analysis. Oxygen consumption was performed as previously described. 36 Briefly, 20 million Blin-1 transfectants were resuspended in 1 ml respiration buffer (20 mM HEPES (pH 7.4), 10 mM MgCl 2 , 250 mM sucrose), placed in a sealed respiration chamber equipped with a thermostat control and a micro-stirring device (Oxytherm; Hansatech Instrument, Norfolk, UK). Oxygen consumption was measured polarographically at 371C using a Clark-type oxygen electrode disc, using the conditions recommended by the manufacturer. Rotenone (100 nM) was added at 5-min intervals, followed by digitonin (30 mg/ml) permeabilization and succinate (5 mM) addition.
Annexin-V analysis. WT and Blin-1 transfectants were incubated with or without 1 mM STS for 8 h. Cells were stained with FITC-Annexin-V (Clontech), washed and analyzed by flow cytometry.
Immunofluorescence microscopy. Blin-1 transfectants were treated with or without 1 mM STS for 8 h. Cells were cytocentrifuged and fixed with 4% paraformaldehyde. Slide preparations were independently reacted with monoclonal anti-Hsp60 and polyclonal anti-CytC (BD Biosciences, San Jose, CA, USA) or anti-AIF (Chemicon, Billerica, MA, USA). Reactivities were respectively revealed using Alexa-488-conjugated anti-mouse and Alexa-594-conjugated anti-rabbit IgGs (Invitrogen). In other experiments, AIF detection was accomplished with a monoclonal IgG and revealed with anti-mouse Alexa-594. TO-PRO (Invitrogen) or Heochst33342 was used as nuclear counterstain. Green, red and blue-fluorescence images were captured by confocal microscopy (Olympus 1X71; PMT 0-900v; scan speed 0.005184 s per line). Similar procedures were used for OPA1 and PRELI detection, with the exception of STS treatment. Monoclonal anti-OPA1 (BD Biosciences) and rabbit anti-PRELI antibodies (custom generated by Bethyl Laboratories, Montgomery, TX, USA) were used here.
DNA fragmentation. Blin-1-and JY DOX-inducible transfectants were incubated for 8 h with or without 1 mM STS. Propidium iodide-stained DNA fragments at the sub-G 1 stage were assessed by flow cytometry.
Immunoblots. Proteins were resolved on 10% SDS-PAGE gels, blotted, reacted with specific antibodies and revealed by chemiluminiscence (DNA Technologies, Gaithersburg, MD, USA). Antibodies for caspase detection were purchased from Cell Signaling Technology, whereas monoclonal antibodies used for respective detection of specific RC complex I-V subunits and OPA1 were purchased from BD Biosciences. For AIF/PRELI or PRELI/LEA À interactions, 1.0 mg V5-tagged PRELI or V5-tagged PRELI/LEA À protein lysates from transient HeLa and DOX-induced Blin-1 transfectants were immunoprecipitated with agarose-conjugated anti-AIF antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and blotted. For OPA1/PRELI or PRELI/LEA À interactions, 1.0 mg of the above cited protein lysates were immunoprecipitated with agarose-conjugated anti-V5 antibody (Invitrogen) and blotted. The blots were reacted with HRP-conjugated anti-V5 monoclonal antibody (Invitrogen) or anti-OPA1 monoclonal antibody followed by an HRP-conjugated anti-mouse IgG reaction.
Transmission electron microscopy. Monolayer breast carcinoma T47D cells grown on glass slides or PRELI Blin-1 transfectants grown in suspension were fixed with a solution containing 0.2% formaldehyde and 0.1% glutaraldehyde. The fixed cells were reacted overnight (ON) at 41C with rabbit polyclonal anti-PRELI antibody, washed three times with PBS and 0.1% Tween (PBST) and then reacted ON at 41C with gold-conjugated anti-rabbit IgG. After subsequent washes with PBST and PBS alone, samples were further fixed with a solution containing 3% glutaraldehyde, 2% formaldehyde and 0.1 M cacodylate (pH 7.3) for 1 h at room temperature (RT). The samples were then washed with cacodylate-buffered tannic acid, post-fixed with 1% osmium tetra-oxide for 1 h at RT and stained in block with 1% uranyl acetate. After dehydration with increasing concentrations of ethanol, samples were embedded in Spurr's low-viscosity solution. Ultra-thin sections were obtained using a microtome (Leica, Bannockburn, IL, USA) and examined with a JEM 1010 transmission electron (JEOL) at an accelerating voltage of 80 kV. Digital images were obtained using an AMT imaging system (Advance Microscopy Techniques Corp., Danvers, MA, USA).
Tg mice. PRELI/LEA
À cDNA was cloned into the pME18S vector 41 for ubiquitous transgene expression, or a 2.3/4.4 (HS21/45) vector 30 for hematopoieticcell-specific expression. Tg mice were generated by the MD Anderson Cancer Center (MDACC) genetic engineering mouse core facility and housed at the MDACC vivarium in compliance with IACUC. 0 . Immunohistochemistry and immunofluorescence. After paraformaldehyde fixing and paraffin embedding, whole-mount embryo sections were prepared for hematoxylin/eosin staining or reaction with anti-His monoclonal antibody (Novagen, Gibbstown, NJ, USA), subsequently revealed by anti-mouse Alexa-488-conjugated IgG (Invitrogen). Paraffin-embedded 5-week Tg mouse spleen and thymus sections were prepared, rehydrated, blocked with SuperBlock (Pierce, Rockford, IL, USA) and reacted ON at 41C with anti-CD3 (BD Biosciences), anti-CD45R/B220 (BD Biosciences) or isotype control antibodies (eBioscience, San Diego, CA, USA). After stringent washes, antibody reactions were revealed using biotinylated anti-species-specific antibodies (BD Biosciences), HRP-conjugated streptavidin (BD Biosciences) and stable DAB (Invitrogen), and using methyl green (Sigma) as counterstain. Images were captured with a pathology enabled Microtek 4000tf scanner (Meyer Instruments, Houston, TX, USA; scan speed 0.005184 s per line) or by confocal microscopy (Olympus 1X71; PMT 0-900v). In situ apoptosis detection. TUNEL staining was performed using whole-mount embryo section, using a TACS TdT apoptosis assay, according to the protocol of R&D Systems. Scans were captured using the pathology enabled Microtek 4000tf scanner.
